Brooks Laboratories Ltd.
BROOKS Share PricePharmaceuticals & Drugs
₹98.5
-0.4 (-0.4%)
As on December 4, 2025
Exchange Scrips: BSE533543NSEBROOKSISININE650L01011
Market Cap ₹ 294 Cr
P/E Ratio -29.11
Dividend Yield N/A
Performance
Market performance
Open98.88
High103.01
Volumes28,778
Prev98.5
Low98
As on2025-12-04
Historical performance
1 Year High198.86
3 Year High198.86
5 Year High198.86
1 Year Low95.25
3 Year Low56.95
5 Year Low49.33
Fundamentals
Company Valuation
Market Cap (₹Cr)
294
Face Value (₹)
10
P/E Ratio
-29.11
Dividend Yield
N/A
Investment Returns
1 Year
-27.3%
3 Years
-15.6%
5 Years
46.1%
10 Years
31.2%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 100.24 | Bearish |
| 10-DMA | 100.95 | Bearish |
| 20-DMA | 102.92 | Bearish |
| 50-DMA | 115.59 | Bearish |
| 100-DMA | 133.26 | Bearish |
| 200-DMA | 131.07 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 8 | 8 | 8 | 9 | 9 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 8 | 8 | 8 | 9 | 9 |
| Public Investors | 10070 | 10309 | 10529 | 10512 | 11273 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of -29.11.
- 3Y Stock Price CAGR of the stock is -5.8.
- The stock has a beta of 1.0.
- In the last financial year, the company had an EBITDA of ₹58 Million.
- The company generated revenue of ₹826 Million in the previous financial year.
Brooks Laboratories Ltd.
98.5-0.4 (-0.4%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 724264.7
No. of Shares: 7353 (Approx)
Performance:-27.6%
P/L: ₹-275735.3
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
